News | January 12, 2022
Indian pharma industry registers 5.3% YoY revenue growth in Dec 2021 : Ind-Ra
Ind-Ra expects revenue growth of over 12% in 2022.
Ind-Ra expects revenue growth of over 12% in 2022.
_256_384.jpg)
Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
Post normalisation of high growth months of April and May this year the average IPM growth from June to August this year stood at 15.2 % YoY : Ind-Ra reports
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
Ind-Ra expects IPM revenue to grow over 12% YoY in FY22
Demand normalisation post the second wave contributed to the steady growth
Subscribe To Our Newsletter & Stay Updated
